Biotech

All Articles

Arrowhead fires off stage 3 data in rare metabolic health condition before market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own give before a prospective face-off along w...

Pfizer, Valneva present lyme disease go successful for second enhancer

.Pfizer and Valneva may have regarding two even more years to stand by prior to they help make the v...

Fierce Biotech Managing Editor Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Permit's dive into a talk along with Ayla Ellison, Fierce Biotech Managing Editor and Michelle Benz...

New data demonstrate how Bayer's asundexian failed to stop strokes

.Bayer put on hold the period 3 trial for its own variable XIa prevention asundexian behind time in ...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its own multiple sclerosis (MS) med tolebrutinib to the FDA, execu...

Galapagos' stockpile as fund shows intent to mold its own progression

.Galapagos is happening under extra tension coming from entrepreneurs. Having actually created a 9.9...

Cell- focused Sana scoops initial CSO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings...

Allist pays off Jacobio $21M, landing function in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has gotten itself a starring character in China's KRAS market, payi...

ReNeuron leaving behind intention swap after overlooking fundraising objective

.ReNeuron has actually participated in the long listing of biotechs to leave London's intention stoc...

MBX apply for IPO to take challenger to Ascendis in to period 3

.MBX Biosciences has contributed to the recent flurry of IPO filings. The biotech, which filed its d...